Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacks

por Bernstein, Jonathan A., Li, Huamin Henry, Craig, Timothy J., Manning, Michael E., Lawo, John-Philip, Machnig, Thomas, Krishnarajah, Girishanthy, Fridman, Moshe
Publicado en Allergy Asthma Clin Immunol (2019)

Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States

por Riedl, Marc A, Banerji, Aleena, Manning, Michael E, Burrell, Earl, Joshi, Namita, Patel, Dipen, Machnig, Thomas, Tai, Ming-Hui, Watson, Douglas J
Publicado en Orphanet J Rare Dis (2018)

Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric Patients with Hereditary Angioedema

por Levy, Donald, Caballero, Teresa, Hussain, Iftikhar, Reshef, Avner, Anderson, John, Baker, James, Schwartz, Lawrence B., Cicardi, Marco, Prusty, Subhransu, Feuersenger, Henrike, Pragst, Ingo, Manning, Michael E.
Publicado en Pediatr Allergy Immunol Pulmonol (2020)

Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial

por Banerji, Aleena, Riedl, Marc A., Bernstein, Jonathan A., Cicardi, Marco, Longhurst, Hilary J., Zuraw, Bruce L., Busse, Paula J., Anderson, John, Magerl, Markus, Martinez-Saguer, Inmaculada, Davis-Lorton, Mark, Zanichelli, Andrea, Li, H. Henry, Craig, Timothy, Jacobs, Joshua, Johnston, Douglas T., Shapiro, Ralph, Yang, William H., Lumry, William R., Manning, Michael E., Schwartz, Lawrence B., Shennak, Mustafa, Soteres, Daniel, Zaragoza-Urdaz, Rafael H., Gierer, Selina, Smith, Andrew M., Tachdjian, Raffi, Wedner, H. James, Hebert, Jacques, Rehman, Syed M., Staubach, Petra, Schranz, Jennifer, Baptista, Jovanna, Nothaft, Wolfram, Maurer, Marcus
Publicado en JAMA (2018)